Literature DB >> 6138247

Down-regulation of prostaglandin E receptors and homologous desensitization of isolated adipocytes.

R P Robertson, S A Little.   

Abstract

Adipocytes are known to contain prostaglandin E (PGE) binding sites and PGE is known to be antilipolytic. These studies were performed to ascertain whether PGE binding sites in isolated adipocytes can be down-regulated and whether down-regulation (DR) decreases the sensitivity of the fat cell to the antilipolytic effects of PGE2, adenosine, and insulin. Treatment in vivo of Sprague-Dawley rats with 16,16-dimethyl-PGE2, a PGE analog, induced DR of PGE-specific binding site density in both intact fat cells (175 vs. 307 fmol/mg protein) and triglyceride-free broken fat cell preparations (148 vs. 360 fmol/mg protein). There were no changes in binding affinities. DR was associated with diminished antilipolytic potency of PGE on basal glycerol production by intact fat cells in the presence of adenosine deaminase (IC50/control = 0.31 +/- 0.03 X 10(-9) M vs. DR = 1.6 +/- 0.03 X 10(-9) M; P less than 0.01). In contrast, there was no desensitization of the adipocytes to the antilipolytic effects of phenylisopropyladenosine (IC50/control = 4.65 +/- 0.96 X 10(-10) M vs. DR = 4.90 +/- 0.82 X 10(-10) M; P = NS) or insulin (IC50/control = 4.40 +/- 0.57 X 10(-11) M vs. DR = 2.70 +/- 0.24 X 10(-11); P = NS). PGE desensitization was also observed during studies of isoproterenol-stimulated lipolysis. These data uniquely demonstrate that the adipocyte PGE receptor can be down-regulated and that this decrease in PGE receptor density is associated with homologous desensitization of the fat cell to the antilipolytic effect of PGE and not adenosine or insulin. These findings suggest that a PGE-specific receptor may be involved in regulation of lipolysis by PGE.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6138247     DOI: 10.1210/endo-113-5-1732

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  Loss of the EP2 prostaglandin E2 receptor in immortalized human keratinocytes results in increased invasiveness and decreased paxillin expression.

Authors:  Raymond L Konger; Glynis A Scott; Yvonne Landt; Jack H Ladenson; Alice P Pentland
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 2.  The role of prostaglandins in altered leukocyte function in multiple sclerosis.

Authors:  P Dore-Duffy; S Y Ho; M Longo
Journal:  Springer Semin Immunopathol       Date:  1985

Review 3.  The Molecular Mechanism Underlying Continuous Exercise Training-Induced Adaptive Changes of Lipolysis in White Adipose Cells.

Authors:  Junetsu Ogasawara; Tetsuya Izawa; Tomonobu Sakurai; Takuya Sakurai; Ken Shirato; Yoshinaga Ishibashi; Hitoshi Ishida; Hideki Ohno; Takako Kizaki
Journal:  J Obes       Date:  2015-05-13

4.  n3 and n6 polyunsaturated fatty acids differentially modulate prostaglandin E secretion but not markers of lipogenesis in adipocytes.

Authors:  Patrick Wortman; Yuko Miyazaki; Nishan S Kalupahana; Suyeon Kim; Melissa Hansen-Petrik; Arnold M Saxton; Kate J Claycombe; Brynn H Voy; Jay Whelan; Naima Moustaid-Moussa
Journal:  Nutr Metab (Lond)       Date:  2009-01-21       Impact factor: 4.169

5.  Prostaglandin E2 receptor, EP3, is induced in diabetic islets and negatively regulates glucose- and hormone-stimulated insulin secretion.

Authors:  Michelle E Kimple; Mark P Keller; Mary R Rabaglia; Renee L Pasker; Joshua C Neuman; Nathan A Truchan; Harpreet K Brar; Alan D Attie
Journal:  Diabetes       Date:  2013-01-24       Impact factor: 9.461

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.